Compare · CNC vs SERA
CNC vs SERA
Side-by-side comparison of Centene Corporation (CNC) and Sera Prognostics Inc. (SERA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNC and SERA operate in Medical Specialities (Health Care), so they compete in similar markets.
- CNC is the larger of the two at $34.83B, about 434.9x SERA ($80.1M).
- CNC has been more active in the news (14 items in the past 4 weeks vs 1 for SERA).
- CNC has more recent analyst coverage (25 ratings vs 8 for SERA).
- Company
- Centene Corporation
- Sera Prognostics Inc.
- Price
- $69.14-1.98%
- $2.04-0.97%
- Market cap
- $34.83B
- $80.1M
- 1M return
- +3.03%
- -
- 1Y return
- +96.07%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 14
- 1
- Recent ratings
- 25
- 8
Centene Corporation
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Sera Prognostics Inc.
Sera Prognostics, Inc., a health diagnostic company, discovers, develops, and commercializes biomarker tests for the early prediction of preterm birth risk and other complications of pregnancy. It develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Latest CNC
- Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma
- SEC Form 4 filed by Centene Corporation
- PA Health & Wellness Earns National Recognition Among Top Medicaid Health Plans for Second Consecutive Year
- Centene to Launch Nationwide Gold Card Program for Qualifying Providers
- SEC Form 8-K filed by Centene Corporation
- Ambetter Health Solutions and Marathon Health Expand Access to Primary Care for Members in Indiana and Missouri
- Wellcare Unveils 2027 Medicare Offerings Focused on Affordability and Integrated Care
- Director Tyler Lauren M was granted 482 shares, increasing direct ownership by 15% to 3,698 units (SEC Form 4)
- Director Tanji Kenneth was granted 603 shares, increasing direct ownership by 5% to 13,093 units (SEC Form 4)
- Director Samuels Theodore R. Ii was granted 583 shares, increasing direct ownership by 2% to 25,796 units (SEC Form 4)
Latest SERA
- SEC Form 4 filed by Sera Prognostics Inc.
- Chief Executive Officer Lindgardt Zhenya sold $14,044 worth of shares (7,022 units at $2.00), decreasing direct ownership by 0.83% to 837,848 units (SEC Form 4) to satisfy withholding tax
- General Counsel Jackson Benjamin sold $4,380 worth of shares (2,190 units at $2.00), decreasing direct ownership by 1% to 159,566 units (SEC Form 4) to satisfy withholding tax
- Chief Commercial Officer Anderson Dyaarl Lee Jr. sold $3,600 worth of shares (1,800 units at $2.00), decreasing direct ownership by 2% to 76,198 units (SEC Form 4) (withholding tax)
- Chief Medical Officer Inglis Tiffany Eul Davis sold $972 worth of shares (486 units at $2.00), decreasing direct ownership by 0.53% to 91,589 units (SEC Form 4) to satisfy withholding obligation
- Chief Executive Officer Lindgardt Zhenya sold $40,278 worth of shares (20,139 units at $2.00), decreasing direct ownership by 2% to 844,870 units (SEC Form 4) (for withholding tax)
- SEC Form 4 filed by Chief Financial Officer Aerts Austin
- SEC Form 3 filed by new insider Gleason Scott
- Chief Financial Officer Gleason Scott was granted 117,924 shares (SEC Form 4)
- 1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.